SenesTech, Inc. SNES
0.89 USD -0.14 (-13.34%)
At closeNov 12, 2026, 5:02 AM EST
0.85 -0.04 -4.77%
Pre-market · Nov 12, 5:02 AM ET
0.77 Day range 1.13
0.55 52-week range 3.40
- YTD
- -58.29%
- 1 year
- -72.02%
News
seekingalpha.com SenesTech, Inc. (SNES) Q3 2026 Earnings Call Transcript SenesTech, Inc. (SNES) Q3 2026 Earnings Call Transcript
benzinga.com SenesTech Q3 EPS $(0.36) Misses $(0.31) Estimate, Sales $1.097M Beat $924.000K Estimate SenesTech (NASDAQ:SNES) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 28.57 percent decrease over losses of $(0.28)…
globenewswire.com SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth Revenue increased 42% sequentially as e-commerce and subscriptions expanded; Gross profit reached a record $796,000 SURPRISE, Ariz., Nov. 10, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES),…
benzinga.com SenesTech Expands Evolve Product Distribution Through Walmart Fulfillment Services SenesTech, Inc. (NASDAQ:SNES), an innovator in rodent birth control, today announced that its Evolve® products are now available through Walmart Fulfillment Services (WFS), expanding the Company’s…
benzinga.com SenesTech 13D Filing Shows Justin LeBeau Discloses 5.4% Stake In Co, Beneficially Owning 294,773 Shares; Calls For Capital Discipline, Reduced Operating Expenses, And An End To Dilutive Equity Offerings Item 4.Purpose of TransactionThe Reporting Person acquired the shares of Common Stock reported herein for investment purposes because he believes the Common Stock is significantly undervalued…
benzinga.com SenesTech Receives Nasdaq Noncompliance Letter; Preliminary Q3 Revenue ~$1.1M SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced that, on Oct. 20, 2026, it received a letter from the listing…
benzinga.com SenesTech Shareholder Glenbrook Capital Discloses Over 30% Stake, Urges Stronger Marketing Strategy And Capital Discipline To Reduce Dilution Glenbrook Believes Better Market Strategy and Sharpened Capitalization Focus Would Create Significant UpsideMINDEN, Nev., Oct. 19, 2026 /PRNewswire/ -- Glenbrook Capital Management ("Glenbrook"), a…- benzinga.com SenesTech Announced Results From A Pilot Of Evolve; Reports Over A 12-Month Period, Standardized Tracking-Tunnel Surveys Documented An 88% Reduction In Average Rat Activity Intensity And An 82% Reduction In The Proportion Of Monitoring Locations With Detectable Rat Activity Rodent-Related 311 Calls in Deployment Area Fell 36% While Citywide Calls IncreasedEvolve® Rat Bith ControlTM Expands to Six Chicago-Area SSAs and WardsSURPRISE, Ariz., Oct. 19, 2026 (GLOBE NEWSWIRE)…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 11.0% to $0.17 during Friday's after-market session. The company's market cap stands at $2.4 million. Lexaria Bioscience…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion. SenesTech (NASDAQ:SNES) stock rose…- benzinga.com SenesTech Reports Q3 Preliminary Revenue Of ~$1.1M, Up 55% YoY SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced preliminary revenue results for the third quarter of 2026. The Company…